GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 23.472
AS - Asia 11.889
EU - Europa 9.740
SA - Sud America 1.584
AF - Africa 311
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 47.045
Nazione #
US - Stati Uniti d'America 23.179
SG - Singapore 3.852
GB - Regno Unito 3.563
CN - Cina 3.336
IT - Italia 1.668
HK - Hong Kong 1.437
BR - Brasile 1.238
VN - Vietnam 1.181
SE - Svezia 860
DE - Germania 799
UA - Ucraina 608
FI - Finlandia 580
TR - Turchia 483
RU - Federazione Russa 412
FR - Francia 362
KR - Corea 339
IN - India 248
BG - Bulgaria 230
BD - Bangladesh 136
ID - Indonesia 122
MX - Messico 120
AR - Argentina 118
IQ - Iraq 112
CA - Canada 111
ES - Italia 107
NL - Olanda 102
PK - Pakistan 101
PL - Polonia 89
ZA - Sudafrica 80
JP - Giappone 78
IE - Irlanda 76
AE - Emirati Arabi Uniti 54
EG - Egitto 54
EC - Ecuador 50
IR - Iran 47
MA - Marocco 46
PH - Filippine 46
AU - Australia 40
LT - Lituania 38
VE - Venezuela 38
CL - Cile 35
CO - Colombia 33
MY - Malesia 33
SA - Arabia Saudita 30
TH - Thailandia 29
BE - Belgio 28
KE - Kenya 28
UZ - Uzbekistan 28
PE - Perù 27
RO - Romania 27
CH - Svizzera 25
DZ - Algeria 25
TN - Tunisia 23
AT - Austria 22
IL - Israele 21
AZ - Azerbaigian 20
JO - Giordania 20
UY - Uruguay 20
CZ - Repubblica Ceca 19
PT - Portogallo 18
PY - Paraguay 16
GR - Grecia 15
KG - Kirghizistan 15
NP - Nepal 14
ET - Etiopia 13
HU - Ungheria 13
KZ - Kazakistan 13
PA - Panama 13
AL - Albania 11
TW - Taiwan 11
BH - Bahrain 10
CR - Costa Rica 10
OM - Oman 10
BO - Bolivia 9
DK - Danimarca 9
SN - Senegal 9
GH - Ghana 8
LB - Libano 8
NG - Nigeria 8
PS - Palestinian Territory 8
EE - Estonia 7
RS - Serbia 7
SY - Repubblica araba siriana 7
NO - Norvegia 6
PR - Porto Rico 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HN - Honduras 5
KH - Cambogia 5
MD - Moldavia 5
NI - Nicaragua 5
SI - Slovenia 5
YE - Yemen 5
KW - Kuwait 4
LK - Sri Lanka 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 46.978
Città #
Southend 2.535
Fairfield 2.494
Singapore 2.266
Ashburn 2.091
Santa Clara 2.087
Woodbridge 1.618
Hong Kong 1.414
Houston 1.277
Jacksonville 1.188
Hefei 1.132
Chandler 1.040
Seattle 915
Wilmington 847
Ann Arbor 772
Cambridge 751
Dearborn 679
Beijing 622
London 592
San Jose 577
Nyköping 534
Chicago 409
Los Angeles 394
Ho Chi Minh City 382
The Dalles 370
Helsinki 345
Modena 341
Seoul 322
Council Bluffs 290
Hanoi 285
Princeton 242
San Diego 237
Sofia 223
Buffalo 208
Eugene 193
Lauterbourg 189
Izmir 168
Salt Lake City 160
Munich 117
Moscow 111
Shanghai 111
São Paulo 108
Milan 105
New York 97
Des Moines 94
Dallas 84
Guangzhou 77
Columbus 76
Frankfurt am Main 74
Elk Grove Village 73
Dublin 72
Orem 69
Rome 69
Bremen 67
Redwood City 66
Tampa 66
Bologna 65
Jakarta 59
Tokyo 54
Haiphong 53
Kent 50
Boardman 49
Da Nang 46
Warsaw 44
Norwalk 43
Rio de Janeiro 41
Turku 41
Baghdad 40
Istanbul 40
Mexico City 40
Falls Church 37
Phoenix 33
Lancaster 32
Sterling 32
Chennai 31
Detroit 31
Johannesburg 30
Miami 30
Cagliari 29
Philadelphia 29
Belo Horizonte 28
Mumbai 28
Amsterdam 27
Dhaka 27
Montreal 27
Parma 27
Redondo Beach 27
Naples 26
Brasília 25
Brooklyn 25
Cairo 25
Kunming 25
Dongguan 24
Nairobi 24
Tashkent 24
Kilburn 23
Atlanta 22
Biên Hòa 22
Lahore 22
Lima 22
Verona 22
Totale 33.226
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 649
Inositol as putative integrative treatment for PCOS 573
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 468
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 395
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 394
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 371
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 367
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 335
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 334
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 324
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 323
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 316
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 312
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 311
Diagnostic and therapeutic approach to hypothalamic amenorrhea 311
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 310
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 310
Use of metformin in the treatment of polycystic ovary syndrome 301
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 301
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 300
Life events impact in patients with secondary amenorrhoea. 299
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 298
Allopregnanolone concentrations and premenstrual syndrome 288
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 288
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 287
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 286
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 281
Inositol and human reproduction. From cellular metabolism to clinical use 278
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 275
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 275
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 272
Advances in neurosteroids: Role in clinical practice 271
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 270
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 266
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 264
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 264
The relevance of inositols treatment for PCOS before and during ART 264
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 263
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 261
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 260
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 260
Obesità e benessere: i rischi per la salute della donna obesa 257
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 256
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 253
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 253
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 250
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 250
Adrenal function under long-term raloxifene administration 247
Episodic secretion of activin A in pregnant women 246
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 241
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 240
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 237
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 235
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 233
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 232
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 230
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 227
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 226
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 225
DHEA as a putative replacement therapy in the elderly 225
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 223
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 223
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 222
Female precocious puberty, obesity and polycystic-like ovaries 221
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 221
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 221
Bollettino di Endocrinologia Ginecologica 219
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 219
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 219
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 219
Which form of HRT should we choose? 217
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 217
Corticotropin-releasing factor-binding protein: Origins and possible functions 217
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 217
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 217
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 216
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 216
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 216
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 215
Progestinici e fibromatosi uterina 214
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 213
Effects of red clover extracts on breast cancer cell migration and invasion 213
. Opioid control of gonadotrophin secretion in humans. 213
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 212
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 212
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 211
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 211
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 210
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 207
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 207
Endocrinologia Ginecologica 206
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts 206
Hypothalamic amenorrhea in a Camurati-Engelmann disease-a case report 205
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 205
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 201
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 201
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 200
Metabolismo osseo nelle amenorreaa ipotalamiche da basso peso: il ruolo del trattamento con estroprogestinici 197
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome 196
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 196
Totale 26.129
Categoria #
all - tutte 188.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.033 0 0 0 0 0 0 0 0 0 572 218 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/20258.093 334 106 80 620 1.540 1.033 358 490 1.091 744 782 915
2025/202614.521 1.059 725 1.632 1.677 2.214 1.332 1.951 908 1.715 1.308 0 0
Totale 47.385